Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) Director Howard Rubin sold 10,000 shares of the company's stock in a transaction on Monday, November 16th. The shares were sold at an average price of $35.57, for a total value of $355,700.00. Following the completion of the transaction, the director directly owned 183,288 shares in the company, valued at approximately $6,519,554.16. This trade represents a 5.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Trupanion Trading Up 1.1%
Shares of NASDAQ TRUP traded up $0.39 during mid-day trading on Tuesday, reaching $36.55. 451,793 shares of the company's stock were exchanged, compared to its average volume of 440,404. The firm has a market capitalization of $1.58 billion, a price-to-earnings ratio of 59.92, a PEG ratio of 1.58 and a beta of 1.27. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.74 and a current ratio of 1.74. Trupanion, Inc. has a 52-week low of $21.16 and a 52-week high of $38.87. The company's 50-day moving average is $27.89 and its 200-day moving average is $26.77.
Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The financial services provider reported $0.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.04. The firm had revenue of $405.59 million during the quarter, compared to the consensus estimate of $402.53 million. Trupanion had a return on equity of 6.71% and a net margin of 1.71%. During the same period last year, the company earned $0.13 EPS. Analysts expect that Trupanion, Inc. will post 0.68 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on the stock. Zacks Research cut shares of Trupanion from a "strong-buy" rating to a "hold" rating in a research report on Monday, August 24th. Cantor Fitzgerald upped their price objective on shares of Trupanion from $30.00 to $33.00 and gave the stock a "neutral" rating in a report on Monday, November 9th. Weiss Ratings raised shares of Trupanion from a "hold (c-)" rating to a "hold (c)" rating in a research report on Tuesday, September 29th. Stifel Nicolaus increased their price objective on shares of Trupanion from $29.00 to $34.00 and gave the stock a "hold" rating in a research report on Monday, November 9th. Finally, Piper Sandler downgraded shares of Trupanion from an "overweight" rating to a "neutral" rating and dropped their target price for the company from $45.00 to $32.00 in a report on Wednesday, August 26th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $40.00.
Read Our Latest Report on Trupanion
Institutional Trading of Trupanion
A number of institutional investors and hedge funds have recently bought and sold shares of TRUP. Sterling Capital Management LLC lifted its position in shares of Trupanion by 843.7% during the third quarter. Sterling Capital Management LLC now owns 1,123 shares of the financial services provider's stock worth $26,000 after purchasing an additional 1,004 shares in the last quarter. Kelleher Financial Advisors acquired a new position in shares of Trupanion in the second quarter valued at approximately $42,000. Parallel Advisors LLC increased its stake in Trupanion by 1,831.9% during the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider's stock worth $47,000 after buying an additional 1,722 shares during the period. Quantbot Technologies LP purchased a new stake in Trupanion during the 2nd quarter worth approximately $89,000. Finally, Fifth Third Bancorp increased its stake in Trupanion by 4.0% during the 3rd quarter. Fifth Third Bancorp now owns 7,772 shares of the financial services provider's stock worth $182,000 after buying an additional 302 shares during the period.
Trupanion Company Profile
(
Get Free Report)
Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.